Ticker > Company >

Sampre Nutritions share price

Sampre Nutritions Ltd.

BSE: 530617 SECTOR: Consumer Food  14k   20   0

71.35
+2.39 (3.47%)
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 71.35

Today's Low

₹ 68.49

52 Week High

₹ 101.17

52 Week Low

₹ 50.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

128.16 Cr.

Enterprise Value

145.55 Cr.

No. of Shares

1.8 Cr.

P/E

114.73

P/B

1.55

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  45.95

CASH

0.11 Cr.

DEBT

17.5 Cr.

Promoter Holding

28.36 %

EPS (TTM)

₹  0.62

Sales Growth

-32.23%

ROE

1.57 %

ROCE

6.38%

Profit Growth

-10.91 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Sampre Nutritions Ltd.

Just Coffee Candy Nutri Orange Delight Mango Delight Fruit Ole Bubble Ole Coffee Ole Sour Ole Tangy Mango Valentine Ole Silli Imli Chilli Imli

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-32.23%
3 Year11.31%
5 Year-2.6%

Profit Growth

1 Year-10.91%
3 Year59.97%
5 Year6.01%

ROE%

1 Year1.57%
3 Year2.24%
5 Year2.12%

ROCE %

1 Year6.38%
3 Year6.53%
5 Year6.66%

Debt/Equity

0.8509

Price to Cash Flow

31.8

Interest Cover Ratio

1.2943

CFO/PAT (5 Yr. Avg.)

7.06339413820115

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 28.36 0.00
Jun 2024 28.36 0.00
Mar 2024 34.99 0.00
Dec 2023 37.03 0.00
Sep 2023 37.03 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -5.89939999999999 days.
  • The company has a good cash flow management; CFO/PAT stands at 7.06339413820115.

 Limitations

  • The company has shown a poor revenue growth of 11.3111538418658% for the Past 3 years.
  • Company has a poor ROE of 2.23640529356455% over the past 3 years.
  • The company is trading at a high PE of 114.73.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 5.96 6.99 4.76 4.51 7.27
Total Expenditure 4.82 6.02 2.65 3.4 6.26
Operating Profit 1.14 0.97 2.11 1.11 1.01
Other Income 0.01 0 0.09 0.03 0
Interest 0.49 0.47 0.48 0.45 0.45
Depreciation 0.31 0.31 0.92 0.44 0.44
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.36 0.2 0.81 0.25 0.13
Tax 0 0 0.26 0 0
Profit After Tax 0.36 0.2 0.55 0.25 0.13
Adjusted EPS (Rs) 0.52 0.29 0.8 0.27 0.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 24.85 18.23 23.13 37.11 25.15
Total Expenditure 20.95 14.8 19.63 33.05 20.95
Operating Profit 3.9 3.43 3.5 4.06 4.2
Other Income 0.18 0.03 0.28 0.07 0.12
Interest 2.13 1.54 1.77 1.89 1.92
Depreciation 1.49 1.81 1.63 1.82 1.83
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.46 0.11 0.37 0.42 0.57
Tax 0.12 0.03 0.06 0.07 0.26
Net Profit 0.34 0.08 0.31 0.35 0.31
Adjusted EPS (Rs.) 0.7 0.16 0.64 0.51 0.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.82 4.82 4.82 6.87 7.27
Total Reserves 5.89 5.96 6.27 14.29 15.28
Borrowings 10.8 12.21 12.76 10.74 9.49
Other N/C liabilities 0.49 0.51 0.51 0.48 0.61
Current liabilities 15.39 14.79 13.34 11.21 12.19
Total Liabilities 37.39 38.29 37.7 43.59 44.83
Assets
Net Block 18.54 17.75 22.18 20.52 21.06
Capital WIP 5.42 5.3 0 4.16 5.5
Intangible WIP 0 0 0 0 0
Investments 0.01 0.01 0.01 0.01 0.03
Loans & Advances 0.48 0.99 1.14 2.53 2.48
Other N/C Assets 0 0 0 0 0
Current Assets 12.94 14.24 14.36 16.36 15.76
Total Assets 37.39 38.29 37.7 43.59 44.83
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.46 0.11 0.37 0.42 0.57
Adjustment 2.39 2.55 3.3 3.59 3.73
Changes in Assets & Liabilities -0.02 -2.63 -0.95 -2.88 -0.48
Tax Paid -0.25 -0.21 -0.32 -0.26 0.22
Operating Cash Flow 2.58 -0.18 2.41 0.88 4.03
Investing Cash Flow -1.26 -0.9 -0.76 -4.32 -3.95
Financing Cash Flow -0.82 0.33 -1.66 3.48 -0.09
Net Cash Flow 0.5 -0.75 -0.01 0.04 -0.02

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 37.03 37.03 34.99 28.36 28.36
brahma gurbani - - 12.21 9.89 9.89
deepa b gurbani 2.07 2.07 1.95 1.58 1.58
meera b gurbani 7.73 7.73 7.30 5.92 5.92
saraswati gurbani 3.23 3.23 3.05 2.48 2.48
sarita b gurbani 11.09 11.09 10.48 8.49 8.49
brahma k gurbani 12.92 12.92 - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 62.97 62.97 65.01 71.64 71.64
ankit gera - - 5.50 4.46 4.46
cheshta batra - - - 5.57 5.57
debashish neogi 1.50 - 2.14 - 1.38
devyani vaghani - - - 2.79 2.79
dipak vaghani - - - - 2.79
jagdish amritlal shah - 1.87 1.77 1.43 1.43
manoj dua - - - - 1.69
neelam mittal - - 2.30 1.70 1.70
nitin sharma - - - - 5.58
rahul rudolph dsouza 2.17 1.97 1.61 1.26 1.14
ram kumar giri - - - 2.23 2.23
roma rudolph dsouza 2.18 2.18 1.98 1.55 1.48
shaaji palliyath - - - - 1.11
shankar nath 1.98 1.98 1.87 1.51 1.51
anilkumar - - 1.54 1.82 -
debashish neogi - - - 1.38 -
dipak vaghani - - - 2.79 -
kamala bai - - 1.23 1.00 -
nitin sharma 1.04 1.03 - 5.57 -
ashok kumar dhingra 1.05 - 1.13 - -
aimann salim govani 1.46 1.46 - - -
foresight holdings pvt. l... - 2.18 - - -
mishal govani 1.46 1.46 - - -
multiplier share & stock ... - 3.84 - - -
salim pyarli govani 1.46 1.46 - - -
sausan bukhari 1.46 1.46 - - -
shivang satish gochha 8.01 4.61 - - -
sonia salim govani 1.46 1.46 - - -
darwin parshottam patel 1.19 - - - -
foresight holdings privat... 2.18 - - - -
vishal singh 1.46 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Sampre Nutritions Stock Price Analysis and Quick Research Report. Is Sampre Nutritions an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Sampre Nutritions stock price today is Rs 71.35. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sampre Nutritions . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sampre Nutritions has a PE ratio of 114.729056118347 which is high and comparatively overvalued .

  • Share Price: - The current share price of Sampre Nutritions is Rs 71.35. One can use valuation calculators of ticker to know if Sampre Nutritions share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sampre Nutritions has ROA of 0.7001 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sampre Nutritions has a Current ratio of 1.2936 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sampre Nutritions has a ROE of 1.5717 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Sampre Nutritions has a Debt to Equity ratio of 0.8509 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Sampre Nutritions has reported revenue growth of -32.2309 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Sampre Nutritions for the current financial year is 16.7047099432134 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sampre Nutritions is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sampre Nutritions is Rs 0.6219 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sampre Nutritions in Ticker for free. Also, one can get the intrinsic value of Sampre Nutritions by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Sampre Nutritions
X